நீண்டது நடிப்பு சிகிச்சை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நீண்டது நடிப்பு சிகிச்சை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நீண்டது நடிப்பு சிகிச்சை Today - Breaking & Trending Today

Nano-Niclosamide Has Potential to Treat COVID-19

Nano-Niclosamide Has Potential to Treat COVID-19
by Angela Mohan on
May 6, 2021 at 9:21 AM
Long-acting injectable therapy has potential to treat COVID-19. In a paper published in the journal
Nanoscale, researchers of the University s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate nanoparticle-based niclosamide as an antiviral candidate.
Researchers started screening of various compounds within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified that shows efficacy against SARS-CoV-2.
CELT scientists used nanoprecipitation to form redispersible solid drug nanoparticle formulations of niclosamide that can be stored as solids, reconstituted with water and utilised as long acting injectables. ....

University Centre Of Excellence , Long Acting Therapeutics , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , நீண்டது நடிப்பு சிகிச்சை ,

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19

Repurposing an existing, cheap drug into long-acting injectable therapy to treat Covid-19
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.
In a paper published in the journal
Nanoscale, researchers from the University s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
The team started repurposing and reformulating identified drug compounds with the potential for COVID-19 therapy candidates within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified and has been shown to be highly effective against SARS-CoV-2 in a number of laboratory studies. ....

United Kingdom , Steve Rannard , Andrew Owen , Emily Henderson , University Centre Of Excellence , University Of Liverpool , Long Acting Therapeutics , Professor Andrew Owen , Professor Steve Rannard , Materials Chemist , Clinical Pharmacology , British Journal , Drug Delivery , Ars Cov 2 , ஒன்றுபட்டது கிஂக்டம் , ஆண்ட்ரூ ஓவந் , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , நீண்டது நடிப்பு சிகிச்சை , ப்ரொஃபெஸர் ஆண்ட்ரூ ஓவந் , பொருட்கள் வேதியியலாளர் , மருத்துவ மருந்தியல் , பிரிட்டிஷ் இதழ் ,

Researchers find potential route to COVID-19 therapy

Researchers find potential route to COVID-19 therapy
ANI
06 May 2021, 03:27 GMT+10
Liverpool [UK], May 5 (ANI): Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.
In a paper published in the journal Nanoscale, researchers from the University s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
The team started repurposing and reformulating identified drug compounds with the potential for COVID-19 therapy candidates within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified and has been shown to be highly effective against SARS-CoV-2 in a number of laboratory studies. ....

United Kingdom , Steve Rannard , Andrew Owen , University Centre Of Excellence , University Of Liverpool , Long Acting Therapeutics , Professor Andrew Owen , Professor Steve Rannard , Clinical Pharmacology , British Journal , ஒன்றுபட்டது கிஂக்டம் , ஆண்ட்ரூ ஓவந் , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , நீண்டது நடிப்பு சிகிச்சை , ப்ரொஃபெஸர் ஆண்ட்ரூ ஓவந் , மருத்துவ மருந்தியல் , பிரிட்டிஷ் இதழ் ,

Researchers discover long-acting injectable medicine as potential route to COVID-19 therapy

Researchers discover long-acting injectable medicine as potential route to COVID-19 therapy
ANI |
Updated: May 05, 2021 22:09 IST
Liverpool [UK], May 5 (ANI): Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.
In a paper published in the journal Nanoscale, researchers from the University s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
The team started repurposing and reformulating identified drug compounds with the potential for COVID-19 therapy candidates within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified and has been shown to be highly effective against SARS-CoV-2 in a number of laboratory ....

United Kingdom , Steve Rannard , Andrew Owen , University Centre Of Excellence , University Of Liverpool , Long Acting Therapeutics , Professor Andrew Owen , Professor Steve Rannard , Clinical Pharmacology , British Journal , Potential Route , Covid 19 Therapy , Professor Steve Rannard , Ars Cov 2 , Anoparticle Formulation Of Niclosamide , Latest Science Related Study , ஒன்றுபட்டது கிஂக்டம் , ஆண்ட்ரூ ஓவந் , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , நீண்டது நடிப்பு சிகிச்சை , ப்ரொஃபெஸர் ஆண்ட்ரூ ஓவந் , மருத்துவ மருந்தியல் , பிரிட்டிஷ் இதழ் , பொடெந்ஶியல் பாதை ,

Long-acting injectable medicine as potential route to COVID-19 therapy

E-Mail
Researchers from the University of Liverpool have shown the potential of repurposing an existing and cheap drug into a long-acting injectable therapy that could be used to treat Covid-19.
In a paper published in the journal
Nanoscale, researchers from the University s Centre of Excellence for Long-acting Therapeutics (CELT) demonstrate the nanoparticle formulation of niclosamide, a highly insoluble drug compound, as a scalable long-acting injectable antiviral candidate.
The team started repurposing and reformulating identified drug compounds with the potential for COVID-19 therapy candidates within weeks of the first lockdown. Niclosamide is just one of the drug compounds identified and has been shown to be highly effective against SARS-CoV-2 in a number of laboratory studies. ....

United Kingdom , Steve Rannard , Andrew Owen , University Centre Of Excellence , University Of Liverpool , Long Acting Therapeutics , Professor Andrew Owen , Professor Steve Rannard , Clinical Pharmacology , British Journal , ஒன்றுபட்டது கிஂக்டம் , ஆண்ட்ரூ ஓவந் , பல்கலைக்கழகம் மையம் ஆஃப் சிறப்பானது , பல்கலைக்கழகம் ஆஃப் லிவர்பூல் , நீண்டது நடிப்பு சிகிச்சை , ப்ரொஃபெஸர் ஆண்ட்ரூ ஓவந் , மருத்துவ மருந்தியல் , பிரிட்டிஷ் இதழ் ,